Breaking News, Collaborations & Alliances

Biomica Enters Service Agreement with Biose Industrie

French CDMO to provide scale-up and GMP production of drug candidates for Biomica’s immuno-oncology program.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Biomica, an emerging biopharmaceutical company developing microbiome-based therapeutics, has entered a service agreement with Biose Industrie, a France based CDMO, for the scale-up production of its drug candidates, microbial consortia BMC121 & BMC127 for its Iimmuno-oncology program.   Biose Industrie is a drug-GMP certified manufacturer of bacteria-based APIs and clinical and commercial products. Biomica engaged with Biose for the scale-up development and GMP production of a clinical batch...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters